{"cluster": 43, "subcluster": 27, "abstract_summ": "We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease\u2013associated pneumonia.We describe a clinical case of coronavirus disease (COVID-19) associated pulmonary aspergillus (CAPA) infection and acute respiratory distress syndrome (ARDS) with a good clinical outcome, in a previously well, non-immunocompromised Australian woman.We detected severe acute respiratory syndrome coronavirus 2 antigen in alveolar epithelial cells and macrophages.As the COVID-19 pandemic has developed, concern for invasive fungal infections in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) has emerged.The emergence of the novel coronavirus or severe acute respiratory syndrome coronavirus 2 leads to a high number of cases of severe pneumonia.", "title_summ": "Cirrhosis and COVID-19: a fatal case of viral peritonitis and disseminated infectionFatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent PatientRecovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU \u2013 A case reportConfirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem managementThe syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two casesInvasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case reportCOVID-19 associated pulmonary aspergillosis (CAPA): An Australian case reportClinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.", "title_abstract_phrases": "Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU \u2013 A case reportAlthough invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA.COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case reportAs the COVID-19 pandemic has developed, concern for invasive fungal infections in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) has emerged.We report a fatal case of invasive pulmonary aspergillosis in an immunocompetent patient in France who had severe coronavirus disease\u2013associated pneumonia.Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent PatientInvasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe influenza pneumonia.The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two casesThe emergence of the novel coronavirus or severe acute respiratory syndrome coronavirus 2 leads to a high number of cases of severe pneumonia."}